Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

INFLAMMATION

IL-6: linking chronic inflammation and vascular calcification

New data highlight the contribution of IL-6 to vascular calcification in chronic inflammation. Given that increased vascular calcification and accelerated atherosclerosis occur in patients with chronic inflammatory diseases, new therapies that block the IL-6 pathway might reduce the risk of cardiovascular events in these patients.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. López-Mejías, R. et al. Cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers. Autoimmun. Rev. 15, 1013–1030 (2016).

    PubMed  Google Scholar 

  2. Vattikuti, R. & Towler, D. A. Osteogenic regulation of vascular calcification: an early perspective. Am. J. Physiol. Endocrinol. Metab. 286, E686–E696 (2004).

    CAS  PubMed  Google Scholar 

  3. Shao, J. S., Cai, J. & Towler, D. A. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler. Thromb. Vasc. Biol. 26, 1423–1430 (2006).

    CAS  PubMed  Google Scholar 

  4. Massy, Z. A. & Hénaut, L. New insights into the key role of interleukin 6 in vascular calcification of chronic kidney disease. Nephrol. Dial. Transplant. 33, 543–548 (2018).

    PubMed  Google Scholar 

  5. Kurozumi, A. et al. IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2. Bone 124, 53–61 (2019).

    CAS  PubMed  Google Scholar 

  6. Castañeda, S., Nurmohamed, M. T. & González-Gay, M. A. Cardiovascular disease in inflammatory rheumatic diseases. Best. Pract. Res. Clin. Rheumatol. 30, 851–869 (2016).

    PubMed  Google Scholar 

  7. Corrales, A. et al. Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. Ann. Rheum. Dis. 72, 1764–1770 (2013).

    CAS  PubMed  Google Scholar 

  8. Rho, Y. H. et al. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 61, 1580–1585 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Fukuyo, S. et al. IL-6-accelerated calcification by induction of ROR2 in human adipose tissue-derived mesenchymal stem cells is STAT3 dependent. Rheumatology 53, 1282–1290 (2014).

    CAS  PubMed  Google Scholar 

  10. López-Mejías, R. et al. Identification of a 3'-untranslated genetic variant of RARB associated with carotid intima-media thickness in rheumatoid arthritis: a genome-wide association study. Arthritis Rheumatol. 71, 351–360 (2019).

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The work of M.A.G.-G is supported by grants from Fondo de Investigación Sanitaria (PI06/0024, PS09/00748, PI12/00060, PI15/00525 and PI18/00043) and RETICS Programs (RD12/0009 and RD16/0012) (RIER) from the Instituto de Salud Carlos III (ISCIII, Health Ministry, Spain) and European Union FEDER funds. R.L.-M. is a recipient of the Miguel Servet type I Program fellowship supported by ISCIII, co-funded by the European Social Fund (“Investing in your future”) (CP16/00033).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Raquel López-Mejías or Miguel A. González-Gay.

Ethics declarations

Competing interests

M.A.G.-G declares that he has received research support from AbbVie, MSD, Jansen and Roche, and has received consultation fees or has participated in a company-sponsored speaker´s bureau from AbbVie, Pfizer, Roche, Sanofi, Celgene, Sobi and MSD. R.L.-M. declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

López-Mejías, R., González-Gay, M.A. IL-6: linking chronic inflammation and vascular calcification. Nat Rev Rheumatol 15, 457–459 (2019). https://doi.org/10.1038/s41584-019-0259-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-019-0259-x

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing